Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors

被引:436
作者
Jutel, M
Watanabe, T
Klunker, S
Akdis, M
Thomet, OAR
Malolepszy, J
Zak-Nejmark, T
Koga, R
Kobayashi, T
Blaser, K
Akdis, CA
机构
[1] Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland
[2] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan
[3] Wroclaw Med Univ, Dept Internal Med & Allergol, PL-50417 Wroclaw, Poland
关键词
D O I
10.1038/35096564
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many pathological processes, including those causing allergies and autoimmune diseases, are associated with the presence of specialized subsets of T helper cells (T(H)1 and T(H)2) at the site of inflammation(1-4). The diversity of T(H)1 and T(H)2 function is not predetermined but depends on signals that drive the cells towards either subset(1-4). Histamine, released from effector cells (mast cells and basophils) during inflammatory reactions can influence immune response(5-8). Here we report that histamine enhances T(H)1-type responses by triggering the histamine receptor type 1 (H1R), whereas both T(H)1- and T(H)2-type responses are negatively regulated by H2R through the activation of different biochemical intracellular signals. In mice, deletion of H1R results in suppression of interferon (IFN)-gamma and dominant secretion of T(H)2 cytokines (interleukin (IL)-4 and IL-13). Mutant mice lacking H2R showed upregulation of both T(H)1 and T(H)2 cytokines. Relevant to T-cell cytokine profiles, mice lacking H1R displayed increased specific antibody response with increased immunoglobulin-e (IgE) and IgG1, IgG2b and IgG3 compared with mice lacking H2R. These findings account for an important regulatory mechanism in the control of inflammatory functions through effector-cell-derived histamine.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 29 条
  • [1] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [2] Role of interleukin 10 in specific immunotherapy
    Akdis, CA
    Blesken, T
    Akdis, M
    Wüthrich, B
    Blaser, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 98 - 106
  • [3] Akdis CA, 2000, FASEB J, V14, P1666
  • [4] IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy
    Akdis, CA
    Blaser, K
    [J]. FASEB JOURNAL, 1999, 13 (06) : 603 - 609
  • [5] Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling
    Banu, Y
    Watanabe, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) : 673 - 682
  • [6] BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55
  • [7] cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes
    Bodor, J
    Spetz, AL
    Strominger, JL
    Habener, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) : 3536 - 3541
  • [8] Induction of NFAT-mediated transcription by G(q)-coupled receptors in lymphoid and non-lymphoid cells
    Boss, V
    Talpade, DJ
    Murphy, TJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) : 10429 - 10432
  • [9] Development of Th1-type immune responses requires the type I cytokine receptor TCCR
    Chen, Q
    Ghilardi, N
    Wang, H
    Baker, T
    Xie, MH
    Gurney, A
    Grewal, IS
    de Sauvage, FJ
    [J]. NATURE, 2000, 407 (6806) : 916 - 920
  • [10] Corry DB, 1999, NATURE, V402, pB18